Utama › Meduloblastoma › California
Kajian klinikal Meduloblastoma di California
6 kajian untuk Meduloblastoma sedang mencari peserta di lokasi di California.
Bandar di California
Teks kajian rasmi (Bahasa Inggeris)
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
- University of California, San Francisco, San Francisco
Mengambil pesertaFasa 1/2
Umur 1 hingga 25 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07346157Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
Mengambil pesertaFasa 2
59 Months · Semua jantina · Dikemas kini 15 Sep 2026 · NCT05535166GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Lucile Packard Children's Hospital Stanford, Palo Alto
Mengambil pesertaFasa 1
Umur 1 hingga 30 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07087002A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- Children's Hospital Los Angeles, Los Angeles
- dan 6 lagi
Mengambil pesertaFasa 3
Umur 4 hingga 21 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- UCSF Benioff Children's Hospital Oakland, Oakland
- UC Davis Comprehensive Cancer Center, Sacramento
- Rady Children's Hospital, San Diego
- dan 1 lagi
Mengambil pesertaFasa 2
Sehingga umur 21 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT04696029Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's Hospital of Los Angeles, Los Angeles
- Rady Children's Hospital, San Diego
- University of California, San Francisco, San Francisco
Mengambil peserta
12 Months – 39 Years · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05057702Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.